TAU Develops Innovative Algorithms To Combat Growth Restrictions Before BirthFor Healthy Hearts
Main Category: Pregnancy / Obstetrics Also Included In: Cardiovascular / Cardiology Neurology / Neuroscience IT / Internet / E-mail Article Date: 11 Nov 2009 When a fetus is smaller than expected for the number of weeks of pregnancy, due to associated problems like a poorly developed heart, health concerns as severe as brain damage can result.
source : www.topix.com
Home Income Profit System
You can make money working from the comfort of your own home!
Get 5 Books for 99 cents!
The most popular books at the most popular prices!
CreditReport.com
Get your credit report and score in just seconds!
Beat your friends on IQ Challenge!
Take the 10-Minute IQ Challenge today. Prove to your friends that you aren't stupid after all!
Take the IQ Challenge!
Are you as stupid as your friends think? Prove them wrong with this quick IQ Challenge game!
You can make money working from the comfort of your own home!
Get 5 Books for 99 cents!
The most popular books at the most popular prices!
CreditReport.com
Get your credit report and score in just seconds!
Beat your friends on IQ Challenge!
Take the 10-Minute IQ Challenge today. Prove to your friends that you aren't stupid after all!
Take the IQ Challenge!
Are you as stupid as your friends think? Prove them wrong with this quick IQ Challenge game!
Related News:
- Growth Of Chronic Kidney Disease Highlights Need For Early Detection, Greater Knowledge Of Treatment Options
- Scientists’ Understanding Of Limb Growth Altered By Roving ‘Sonic Hedgehog’ Gene
- Novo Nordisk Receives FDA Approval For Norditropin® FlexPro® For Growth Hormone Treatment
- Keeping Tumor Growth Switched Off: New Drug Created By Researchers
- Melatonin Precursor Stimulates Growth Factor Circuits In Brain
- Green Tea Extracts Halt Growth of Prostate Cancer Tumors
- AM: Nerve Growth Factor Antibody May Reduce Pain (CME/CE)
- Growth Factor Gene Shown To Be A Key To Cleft Palate
- Fat Behaves Differently In Patients With Polycistic Ovary Syndrome
- PROLOR Biotech Reports Positive Top-Line Results From Phase I Study Of Its Longer-Acting Version Of Human Growth Hormone
Details :
Submited at Thursday, November 12th, 2009 at 7:00 am on Obstetrics & Gynaecology by Gillan
Comment RSS 2.0 - leave a comment - trackback
Leave Comment Here...
















